-
The Relevance of Intellectual Property for Pharmaceutical Innovation
By Mr Maarten Meulenbelt, Sidley Austin LLP* In the pharmaceutical industry, the role of Intellectual Property (IP) as an incentive for product development is particularly important: each investor...
-
Episode 78: IP in the EU FTA’s Series: Relevance of IP for the Innovative Pharmaceutical Industry with Nathalie Moll
In this online conversation, Jacki Davis talks to Nathalie Moll, Director-General of EFPIA – the European Federation of Pharmaceutical Industries and Associations, which supported the...
-
Episode 71: IP in the EU FTA’s Series: Introduction to the Project with Fredrik Erixon
In this online conversation, Jacki Davis talks to Fredrik Erixon, the Director of ECIPE and an author of the recent study titled: "The Benefits of Intellectual Property Rights in EU Free Trade...
-
The European Commission’s pharmaceutical innovation incentives review is at risk of serious overreach
Philip Stevens is executive director of Geneva Network, a UK-based research organisation working on international innovation and trade policy. Over the summer, the European Commission (EC)...